Moving Research and Management Forward for Men with Treatment-Resistant Metastatic Prostate Cancer
Researchers Oliver Sartor, MD (Tulane Cancer Center), Andrew Armstrong, MD, MSc (Duke University) and Rob Reiter, MD (UCLA), hosted an educational session at the American Society of Clinical Oncology meeting titled, “State-of-the-Art Management for the Patient with Castration-Resistant Prostate Cancer in 2012.” The research trio addresses questions, and more, online.
Also in News
Why does Lindi Skin contain fragrances?
Fragrance is one of the key decisions to be made when creating any skincare products, and our team of doctors, formulators and skincare experts created our formulas with very explicit instructions to design the products without any unnecessary fragrances, dyes, or ingredients.
However, the key word here is “unnecessary”.